Pet clinics文章索引

Preface [0.03%] 前言

David A Mankoff David A Mankoff

Editorial PET clinics. 2008 Jan;3(1):ix-x. DOI:10.1016/j.cpet.2008.10.005 2008

PET for Therapeutic Response Monitoring in Oncology [0.03%] 正电子发射断层扫描在肿瘤治疗反应监测中的应用

Rodney J Hicks Rodney J Hicks

After diagnosis and staging of cancer, the most important process in modern oncology is assessment of therapeutic response. Timely identification of patients with poor response may allow introduction of alternative therapies, sparing patien...

Review PET clinics. 2008 Jan;3(1):89-99. DOI:10.1016/j.cpet.2008.09.003 2008

FDG-PET to Measure Response to Targeted Therapy: The Example of Gastrointestinal Stromal Tumor and Imatinib Mesylate (Gleevec) [0.03%] FDG-PET测定靶向治疗的效果：胃肠道间质瘤和甲磺酸伊马替尼(Gleevec)的实例分析

Annick D Van den Abbeele,Mehmet Ertuk Annick D Van den Abbeele

Imaging has played a major role in the evaluation of molecular targeted therapies in patients with gastrointestinal stromal tumors. FDG-PET has been instrumental in the evaluation of the tyrosine kinase inhibitors used to treat this disease...

Review PET clinics. 2008 Jan;3(1):77-87. DOI:10.1016/j.cpet.2008.08.001 2008

FDG-PET Evaluation of Response to Treatment [0.03%] 疗效评估的FDG-PET检查

Lale Kostakoglu Lale Kostakoglu

This article discusses evaluating response after and during therapy in various settings and for the types of cancers for which ample evidence demonstrates that PET imaging with flourodeoxyglucose provides a valuable surrogate for response t...

Review PET clinics. 2008 Jan;3(1):37-75. DOI:10.1016/j.cpet.2008.09.001 2008

Variables Involved in Measuring Cancer Response to Treatment [0.03%] 与癌症治疗反应测量有关的变量

Lale Kostakoglu Lale Kostakoglu

In this article, the discussions about concepts involved in anticancer therapy, including cell death pathways and the variables that guide clinical management, such as intents and types of anticancer therapy regimens and modalities, are a p...

Review PET clinics. 2008 Jan;3(1):13-36. DOI:10.1016/j.cpet.2008.08.002 2008

Quantitative Issues in Response Measurement by PET [0.03%] 正电子发射体层摄影响应测量中的定量问题

Adriaan A Lammertsma,Ronald Boellaard,Otto S Hoekstra Adriaan A Lammertsma

Monitoring response to anticancer therapy requires a (semi)quantitative PET approach. In this review, several instrumentation and analysis issues that have an impact on quantification are discussed. These issues are divided into the followi...

Review PET clinics. 2008 Jan;3(1):5-11. DOI:10.1016/j.cpet.2008.08.003 2008

Standardization of PET Imaging in Clinical Trials [0.03%] 临床试验中PET显像的标准化

Lalitha K Shankar Lalitha K Shankar

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. In vitro biomarkers include histopathol...

Review PET clinics. 2008 Jan;3(1):1-4. DOI:10.1016/j.cpet.2008.10.006 2008

Preface [0.03%] 前言

Todd M Blodgett,Melanie B Fukui Todd M Blodgett

Editorial PET clinics. 2007 Oct;2(4):xi. DOI:10.1016/j.cpet.2008.09.005 2007

Radiation Treatment Planning for Head and Neck Malignancies [0.03%] 头颈部恶性肿瘤的放射治疗计划

Regiane S de Andrade,Dwight E Heron Regiane S de Andrade

Innovative approaches have been incorporated to radiation therapy over the last decades. The technologic advances, such as intensity modulated radiation therapy and image guided radiation have resulted in a modern era for this oncologic mod...

Review PET clinics. 2007 Oct;2(4):511-9. DOI:10.1016/j.cpet.2008.05.005 2007

PET Imaging of Skull Base Neoplasms [0.03%] skull base肿瘤的正电子发射断层显像术(PET imaging)

Erik S Mittra,Andrei Iagaru,Andrew Quon et al. Erik S Mittra et al.

The utility of 18-F-fluorodeoxyglucose-positron emission tomography (PET) and PET/CT for the evaluation of skull base tumors is incompletely investigated, as a limited number of studies specifically focus on this region with regard to PET i...

Review PET clinics. 2007 Oct;2(4):489-510. DOI:10.1016/j.cpet.2008.05.006 2007